Prostate Cancer Research (PCR) and CellCentric are delighted to announce a new collaborative partnership focused on creating a new patient-focused information and engagement program for people affected by prostate cancer.
CellCentric has provided an educational grant to PCR to help us better understand the prostate cancer patient journey and support the development of PCR’s new patient program, which aims to engage people with prostate cancer in the latest research and clinical developments within universities and industry.
Through this new patient information and engagement program, PCR aims to ensure that our patient community is informed, connected and empowered. This new digital platform will enable people to easily and freely access clear and concise information on the latest developments in prostate cancer research. It will also enable patients to engage with this research by providing insights from their own lived experiences. In doing so, we aim to ensure that the drugs of the future are developed with the patient’s quality of life impact as a top priority.